Pharmacyclics Inc (NASDAQ:PCYC)

124.97
Data as of Sep 18
 +1.55 / +1.26%
Today’s Change
82.51
Today|||52-Week Range
154.89
+18.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$9.3B

Company Description

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has three product candidates in clinical development and several preclinical molecules in lead optimization. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. Pharmacyclics was founded on April 19, 1991 and is headquartered in Sunnyvale, CA.

Contact Information

Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale California 94085-4521
P:(408) 774-0330
Investor Relations:

Employees

Shareholders

Mutual fund holders42.82%
Individual stakeholders33.24%
Other institutional32.40%

Top Executives

Robert W. DugganChairman & Chief Executive Officer
Mahkam ZanganehChief Operating Officer
Manmeet Singh SoniChief Financial Officer
James N. LowderVice President-Clinical Development
Jesse Seton McGreivyChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.